The magical microbiome
By Brittany Niccum and Han Wei Now that we are past the holiday season and…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportBy Brittany Niccum and Han Wei Now that we are past the holiday season and…
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the…
Perhaps 2022 will best be remembered in the life science industry for the return of…
Each month here at Labiotech.eu, we produce a special newsletter. While still news-related, these special…
Biomica Ltd., a subsidiary of Evogene Ltd., has signed a definitive agreement for a $20…
The news last week of the FDA approving Ferring Pharmaceuticals' first fecal microbiome product, Rebyota,…
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA)…
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
Disruption in the gut microbiome is linked to a wide range of health problems in…
Many cancer patients cannot benefit from cancer immunotherapy because their tumors are protected from the…
Clinical Microbiomics, a microbiome research company, has acquired MS-Omics, a metabolomics provider based in Denmark. …
Skin microbiome research could lead to new approaches for addressing organ damage after stem cell…